Watson Latest Target Of Amarin's Vascepa Patent Suits
Amarin Pharma Inc. filed suit against Actavis Inc. and subsidiary Watson Laboratories Inc. in New Jersey federal court Wednesday, alleging they are infringing a number of patents for high-fat treatment Vascepa...To view the full article, register now.
Already a subscriber? Click here to view full article